Suppr超能文献

子宫内膜癌生存者的第二原发结直肠癌:共同的病因和治疗后遗症。

Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae.

机构信息

Cancer Healthcare Research Branch, Research Institute, National Cancer Center, Goyang, Republic of Korea.

Center for Uterine Cancer, Hospital, National Cancer Center, Goyang, Republic of Korea.

出版信息

J Cancer Res Clin Oncol. 2018 May;144(5):845-854. doi: 10.1007/s00432-018-2599-3. Epub 2018 Feb 14.

Abstract

PURPOSE

To evaluate the incidence of colon cancer as a second primary cancer (CCSPC) and the survival outcomes of women with and without CCSPC after the diagnosis of endometrial cancer (EC).

METHODS

The standardized incidence ratio (SIR) of CCSPC and survival outcomes of EC survivors with and without CCSPC were analyzed using data from January 1 1993 to December 31 2011, obtained from the Korea Central Cancer Registry.

RESULTS

Of 14,797 EC survivors, 147 (0.99%) developed CCSPC after an average interval of 5.5 years. The SIR of CCSPC among EC survivors was 2.56, higher than that of colon cancer in the general population. The SIR of CCSPC was highest for the ascending (3.77), followed by the transverse (3.45), descending colon (2.06), and rectum (1.99). The risk of a proximal site of CCSPC was high, especially within 5 years after the diagnosis of EC in the ascending (SIR, 4.37) and transverse (4.91) colon, and in young survivors (< 60 years) in the ascending (5.19) and transverse (3.82) colon. The 5- and 10-year overall survival rates were 84.8 and 80.4% among survivors with EC only and 89.2 and 76.3% for survivors with CCSPC, respectively.

CONCLUSIONS

The risk of CCSPC among EC survivors increases especially in the proximal colon in young survivors. These results could be used for surveillance and counseling of EC survivors.

摘要

目的

评估女性子宫内膜癌(EC)诊断后发生结直肠癌作为第二原发癌(CCSPC)的发生率及有无CCSPC 的 EC 幸存者的生存结局。

方法

利用韩国中央癌症登记处 1993 年 1 月 1 日至 2011 年 12 月 31 日的数据,分析了 CCSPC 的标准化发病比(SIR)和有无 CCSPC 的 EC 幸存者的生存结局。

结果

在 14797 例 EC 幸存者中,平均间隔 5.5 年后有 147 例(0.99%)发生 CCSPC。EC 幸存者中 CCSPC 的 SIR 为 2.56,高于普通人群中结肠癌的 SIR。CCSPC 的 SIR 以升结肠最高(3.77),其次为横结肠(3.45)、降结肠(2.06)和直肠(1.99)。CCSPC 的近端部位风险较高,尤其是在 EC 诊断后 5 年内,升结肠(SIR,4.37)和横结肠(4.91)以及年轻幸存者(<60 岁)的升结肠(5.19)和横结肠(3.82)。仅有 EC 的幸存者的 5 年和 10 年总生存率分别为 84.8%和 80.4%,而有 CCSPC 的幸存者分别为 89.2%和 76.3%。

结论

EC 幸存者发生 CCSPC 的风险增加,尤其是在年轻幸存者的近端结肠。这些结果可用于 EC 幸存者的监测和咨询。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a26/11813519/b987d783f715/432_2018_2599_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验